CanniMed was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis grown under conditions that comply with pharmaceutical manufacturing standards. Our goal is to provide improved access for Canadians who rely on medical marijuana to manage the symptoms of chronic disabilities and terminal illnesses, while maintaining safety standards and reliability.